CLINICAL STUDIES
Validation of the in vivo intravascular ultrasound measurement of in-stent neointimal hyperplasia volumes
Roxana Mehran, MDa,
Gary S. Mintz, MD, FACCa,
Mun K. Hong, MD, FACCa,
Fermin O. Tio, MD*,
Orville Bramwell, BAa,
Abdel Brahimi, MDa,
Kenneth M. Kent, MD, PhD, FACCa,
Augusto D. Pichard, MD, FACCa,
Lowell F. Satler, MD, FACCa,
Jeffrey J. Popma, MD, FACCa and
Martin B. Leon, MD, FACCa
a Intravascular Ultrasound Imaging and Cardiac Catheterization Laboratories, Washington Hospital Center, Washington, DC, USA
* University of Texas, San Antonio, Texas, USA
Manuscript received April 14, 1997;
revised manuscript received May 14, 1998,
accepted May 20, 1998.
Address for correspondence: Dr. Martin B. Leon, Washington Cardiology Center, 110 Irving Street NW, Suite 4B1, Washington, DC 20010
Objectives. This study was undertaken to validate the in vivo intravascular ultrasound (IVUS) measurement of in-stent neointimal hyperplasia (IH) volumes.
Background. Because stents reduce restenosis compared to balloon angioplasty, stent use has increased significantly. As a result, in-stent restenosis is now an important clinical problem. Serial IVUS studies have shown that in-stent restenosis is secondary to intimal hyperplasia. To evaluate strategies to reduce in-stent restenosis, accurate measurement of in-stent neointimal tissue is important.
Methods. Using a porcine coronary artery model of in-stent restenosis, single PalmazSchatz stents were implanted into 16 animals with a stent:artery ratio of 1.3:1. Intravascular ultrasound imaging was performed at 1 month, immediately prior to animal sacrifice. In vivo IVUS and ex vivo histomorphometric measurements included stent, lumen and IH areas; IH volumes were calculated with Simpsons rule.
Results. Intravascular ultrasound measurements of IH (30.4 ± 11.0 mm3) volumes correlated strongly with histomorphometric measurements (26.7 ± 8.5 mm3, r = 0.965, p < 0.0001). The difference between the IVUS and the histomorphometric measurements of IVUS volume was 4.1 ± 2.7 mm3 or 15.8 ± 11% (standard error of the estimate = 0.7). Both histomophometry and IVUS showed that IH was concentric and uniformly distributed over the length of the stent. Intravascular ultrasound detected neointimal thickening of 0.2 mm in 5 of 16 stents.
Sample size calculations based on the IVUS measurement of IH volumes showed that 12 stented lesions/arm would be required to show a 50% reduction in IVUS-measured IH volume and 44 stented lesions/arm would be required to show a 25% reduction in IH volume.
Conclusions. In vivo IVUS measurement of IH volumes correlated strongly with ex vivo histomorphometry. Using volumetric IVUS end points, small sample sizes should be necessary to demonstrate effectiveness of strategies to reduce in-stent restenosis.
|
Abbreviations and Acronyms
| | CSA | = cross-sectional area | | DS | = diameter stenosis | | IH | = intimal hyperplasia | | IVUS | = intravascular ultrasound | | MLD | = minimum lumen diameter | | QCA | = quantitative coronary angiography |
|
This article has been cited by other articles:

|
 |

|
 |
 
H Kaneda, T Shiono, Y Miyashita, S Takahashi, Y Taketani, H Domae, J Matsumi, S Mizuno, Y Minami, K Sugitatsu, et al.
Efficacy and safety of pioglitazone in patients with ST elevation myocardial infarction treated with primary stent implantation
Heart,
July 1, 2009;
95(13):
1079 - 1084.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J Russo, P. D Silva, and M. Yeager
Coronary artery overexpansion increases neointimal hyperplasia after stent placement in a porcine model
Heart,
December 1, 2007;
93(12):
1609 - 1615.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kawasaki, B. E. Bouma, J. Bressner, S. L. Houser, S. K. Nadkarni, B. D. MacNeill, I.-K. Jang, H. Fujiwara, and G. J. Tearney
Diagnostic Accuracy of Optical Coherence Tomography and Integrated Backscatter Intravascular Ultrasound Images for Tissue Characterization of Human Coronary Plaques
J. Am. Coll. Cardiol.,
July 4, 2006;
48(1):
81 - 88.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D Perera, P Postema, R Rashid, S Patel, L Blows, M Marber, and S Redwood
Does a well developed collateral circulation predispose to restenosis after percutaneous coronary intervention? An intravascular ultrasound study
Heart,
June 1, 2006;
92(6):
763 - 767.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. K. Prasad, K. R. Resmi, L. K. Krishnan, and R. Vaishnav
Survival of Endothelial Cells in vitro on Paclitaxel-loaded Coronary Stents
J Biomater Appl,
April 1, 2005;
19(4):
271 - 286.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Chaves, A. G.M.R. Sousa, L. A. Mattos, A. Abizaid, R. Staico, F. Feres, M. Centemero, L. F. Tanajura, A. Abizaid, I. Pinto, et al.
Volumetric Analysis of In-Stent Intimal Hyperplasia in Diabetic Patients Treated With or Without Abciximab: Results of the Diabetes Abciximab steNT Evaluation (DANTE) Randomized Trial
Circulation,
February 24, 2004;
109(7):
861 - 866.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Hoffmann, C. Jansen, A. Konig, P.K. Haager, G. Kerckhoff, J. Vom Dahl, V. Klauss, P. Hanrath, and H. Mudra
Stent design related neointimal tissue proliferation in human coronary arteries; an intravascular ultrasound study
Eur. Heart J.,
November 1, 2001;
22(21):
2007 - 2014.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Hoffmann, P. Haager, G.S. Mintz, G. Kerckhoff, R. Schwarz, A. Franke, J. Vom Dahl, and P. Hanrath
The impact of high pressure vs low pressure stent implantation on intimal hyperplasia and follow-up lumen dimensions; results of a randomized trial
Eur. Heart J.,
November 1, 2001;
22(21):
2015 - 2024.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
F Schiele, M K Batur, M F Seronde, N Meneveau, P Sewoke, A Bassignot, G Couetdic, F Caulfield, and J-P Bassand
Cytomegalovirus, Chlamydia pneumoniae, and Helicobacter pylori IgG antibodies and restenosis after stent implantation: an angiographic and intravascular ultrasound study
Heart,
March 1, 2001;
85(3):
304 - 311.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. S. Mintz, N. J. Weissman, P. S. Teirstein, S. G. Ellis, R. Waksman, R. J. Russo, I. Moussa, P. Tripuraneni, S. Jani, Y. Kobayashi, et al.
Effect of Intracoronary {{gamma}}-Radiation Therapy on In-Stent Restenosis : An Intravascular Ultrasound Analysis from the Gamma-1 Study
Circulation,
December 12, 2000;
102(24):
2915 - 2918.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N Meneveau, F Schiele, G Grollier, B Farah, J.M Lablanche, K Khalife, J Machecourt, N Danchin, J.E Wolf, M Simpson, et al.
Local delivery of nadroparin for the prevention of neointimal hyperplasia following stent implantation: results of the IMPRESS Trial. A multicentre, randomized, clinical, angiographic and intravascular ultrasound study
Eur. Heart J.,
November 1, 2000;
21(21):
1767 - 1775.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kozuma, M. A. Costa, M. Sabate, I. P. Kay, J. P. A. Marijnissen, V. L. M. A. Coen, P. Serrano, J. M. R. Ligthart, P. C. Levendag, and P. W. Serruys
Three-Dimensional Intravascular Ultrasound Assessment of Noninjured Edges of {beta}-Irradiated Coronary Segments
Circulation,
September 26, 2000;
102(13):
1484 - 1489.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Mehran, G. Dangas, A. S. Abizaid, G. S. Mintz, A. J. Lansky, L. F. Satler, A. D. Pichard, K. M. Kent, G. W. Stone, and M. B. Leon
Angiographic Patterns of In-Stent Restenosis : Classification and Implications for Long-Term Outcome
Circulation,
November 2, 1999;
100(18):
1872 - 1878.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|